Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and ...